Viatris Inc. buy melinda
Start price
04.10.17
/
50%
€34.35
Target price
29.12.17
€42.39
Performance (%)
10.68%
End price
29.12.17
€38.02
Summary
This prediction ended on 29.12.17 with a price of €38.02. The BUY prediction by melinda finished with a performance of 10.68%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viatris Inc. | -1.179% | -1.179% | 82.480% | 53.056% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% | 56.109% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% | 92.063% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% | 79.139% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% | 70.019% |
Comments by melinda for this prediction
In the thread Viatris Inc. diskutieren
Der Kurs MYL Mylan Inc. zu folgen hat einen neuen Höchststand von 26 Wochen erreicht
$$
Die Mylan Inc MYL Preis hat einen neuen Höchststand von 26 Wochen erreicht
NV Mylan (MYL) gewinnt FDA - Zulassung für die erste Generation Copaxone; Die Aktie stieg um 17%
(Vom Mitglied beendet)